{"id":794,"date":"2026-10-20T03:13:24","date_gmt":"2026-10-20T01:13:24","guid":{"rendered":"http:\/\/novameds.local\/fr\/?post_type=product&#038;p=794"},"modified":"2026-10-20T03:59:55","modified_gmt":"2026-10-20T01:59:55","slug":"catalog-ru58841-powder-5-grams","status":"publish","type":"product","link":"https:\/\/novameds.health\/fr\/produit\/catalog-ru58841-powder-5-grams\/","title":{"rendered":"RU58841 \u2013 Powder, 5 grams"},"content":{"rendered":"<section id=\"composition\" data-nav=\"Composition et d\u00e9tails du produit\">\n<h2>Composition et d\u00e9tails du produit<\/h2>\n<div class=\"nm-catalog-document\">\n<div>\n<h2>Pr\u00e9sentation<\/h2>\n<div>\n<p>RU58841 (PSK-3841) is a non-steroidal androgen receptor (AR) antagonist developed to selectively inhibit AR-mediated signaling pathways. Experimental investigations have demonstrated that RU58841 competes with androgenic ligands for binding to the androgen receptor, preventing receptor activation and downstream transcriptional activity.<\/p>\n<p>Research has examined its interactions with AR-associated regulatory mechanisms, ligand-receptor dynamics, nuclear receptor signaling pathways, and transcriptional control processes governed by androgen receptor activation.<\/p>\n<p>Its well-characterized antagonist profile makes RU58841 a valuable research tool for studies of androgen receptor pharmacology, AR-mediated signal transduction, receptor-ligand competition, nuclear receptor regulation, and comparative investigations of androgen receptor antagonists.<\/p>\n<ul>\n<li> <span><b>High Purity<\/b> \u2013 99% Purity Guaranteed<\/span><\/li>\n<li> Independently Lab Tested<\/li>\n<li> Research Grade Quality<\/li>\n<li> For Laboratory Research Use Only<\/li>\n<\/ul><\/div>\n<div>\n<p><a href=\"https:\/\/pubchem.ncbi.nlm.nih.gov\/compound\/132981\" target=\"_blank\" rel=\"noopener noreferrer\">Donn\u00e9es mol\u00e9culaires sur PubChem<\/a><\/p>\n<\/p><\/div>\n<\/p><\/div>\n<div>\n<h2>Propri\u00e9t\u00e9s<\/h2>\n<div class=\"nm-catalog-table\" tabindex=\"0\" role=\"region\" aria-label=\"Product data\">\n<table>\n<tbody>\n<tr>\n<th>Chemical Formula<\/th>\n<td>C17H18F3N3O3<\/td>\n<\/tr>\n<tr>\n<th>Synonyms<\/th>\n<td>PSK-3841, HMR-3841, 4-[3-(4-Hydroxybutyl)-4,4-dimethyl-2,5-dioxo-1-imidazolidinyl]-2-(trifluoromethyl)benzonitrile<\/td>\n<\/tr>\n<tr>\n<th>Molar Mass<\/th>\n<td>369.34 g\/mol<\/td>\n<\/tr>\n<tr>\n<th>CAS Number<\/th>\n<td>154992-24-2<\/td>\n<\/tr>\n<tr>\n<th>PubChem CID<\/th>\n<td>132981<\/td>\n<\/tr>\n<tr>\n<th>Total Compound Content<\/th>\n<td>5 g powder<\/td>\n<\/tr>\n<tr>\n<th>Shelf Life<\/th>\n<td>36 months<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div><\/div>\n<div>\n<h2>Recherche<\/h2>\n<p>\t\t\t\t\t<span>RU58841 (PSK-3841) is a hydantoin-class non-steroidal androgen receptor (AR) antagonist that functions through competitive inhibition of androgen receptor signaling. Experimental investigations have demonstrated that RU58841 competes with androgenic ligands for binding to the AR ligand-binding domain, preventing receptor activation and subsequent transcriptional activity. Research has examined its interactions with AR-associated regulatory mechanisms, ligand-receptor dynamics, nuclear receptor signaling pathways, and androgen-responsive gene regulation. Its antagonist profile and well-characterized receptor interactions make RU58841 a valuable research tool for studies of androgen receptor pharmacology, AR-mediated signal transduction, receptor-ligand competition, nuclear receptor regulation, and comparative investigations of androgen receptor antagonists. Supplied as powder (5 g). Independently third-party HPLC-tested; COA available per batch.<\/span>\t\t\t\t\t<\/div>\n<div>\n<h2>FAQ<\/h2>\n<div>\n<details>\n<summary>\n\t\t\t\t\t\t\t\t\t\t<span>Why was RU58841 developed as a locally acting androgen receptor antagonist?<\/span><\/p>\n<\/summary>\n<div>\n<p>RU58841 was developed as a non-steroidal androgen receptor antagonist for investigations of localized AR-mediated signaling pathways.<\/p>\n<p>Its pharmacological profile has made it a useful research tool for examining androgen receptor activity within defined experimental systems while studying receptor-ligand interactions, androgen-responsive gene regulation, and AR-dependent signal transduction mechanisms. This distinguishes RU58841 from compounds primarily utilized for broader systemic androgen receptor pharmacology studies.<\/p>\n<\/div>\n<\/details>\n<details>\n<summary>\n\t\t\t\t\t\t\t\t\t\t<span>How does RU58841&rsquo;s androgen receptor affinity compare with other AR ligands?<\/span><\/p>\n<\/summary>\n<div>\n<p>RU58841 exhibits high affinity for the androgen receptor and functions as a competitive antagonist at the AR ligand-binding domain. Experimental studies have utilized RU58841 in receptor-binding assays, ligand competition experiments, and investigations of androgen receptor activation mechanisms.<\/p>\n<p>Its well-characterized antagonist profile makes it a valuable reference compound for comparative studies of androgen receptor pharmacology and receptor-ligand dynamics.<\/p>\n<\/div>\n<\/details>\n<details>\n<summary>\n\t\t\t\t\t\t\t\t\t\t<span>What formulation characteristics make RU58841 powder useful for research applications?<\/span><\/p>\n<\/summary>\n<div>\n<p>RU58841 powder provides flexibility for preparation in a variety of experimental systems, including receptor-binding assays, cell-based signaling studies, gene expression analyses, and formulation development investigations. The powder format allows researchers to prepare defined concentrations in assay-specific solvents and vehicles, supporting studies of androgen receptor signaling, concentration-response relationships, receptor occupancy, and comparative pharmacological evaluation of AR antagonists.<\/p>\n<\/div>\n<\/details><\/div>\n<\/p><\/div>\n<\/div>\n<\/section>\n","protected":false},"excerpt":{"rendered":"<p>RU58841 (PSK-3841) is a non-steroidal androgen receptor (AR) antagonist developed to selectively inhibit AR-mediated signaling pathways.<\/p>\n<p>Conditionnement: RU58841 \u2013 Powder, 5 grams.<\/p>\n<p class=\"nm-research-disclaimer\">R\u00e9serv\u00e9 \u00e0 la recherche en laboratoire. Ne pas utiliser chez l\u2019\u00eatre humain ou l\u2019animal.<\/p>\n<p class=\"nm-catalog-image-note\"><small>Conditionnement illustratif g\u00e9n\u00e9r\u00e9 par IA.<\/small><\/p>\n","protected":false},"featured_media":986,"comment_status":"closed","ping_status":"closed","template":"","meta":[],"product_brand":[],"product_cat":[24],"product_tag":[],"nm_classification":[],"class_list":["post-794","product","type-product","status-publish","has-post-thumbnail","product_cat-cognitive-health-nootropics","first","instock","shipping-taxable","product-type-simple"],"_links":{"self":[{"href":"https:\/\/novameds.health\/fr\/wp-json\/wp\/v2\/product\/794","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/novameds.health\/fr\/wp-json\/wp\/v2\/product"}],"about":[{"href":"https:\/\/novameds.health\/fr\/wp-json\/wp\/v2\/types\/product"}],"replies":[{"embeddable":true,"href":"https:\/\/novameds.health\/fr\/wp-json\/wp\/v2\/comments?post=794"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/novameds.health\/fr\/wp-json\/wp\/v2\/media\/986"}],"wp:attachment":[{"href":"https:\/\/novameds.health\/fr\/wp-json\/wp\/v2\/media?parent=794"}],"wp:term":[{"taxonomy":"product_brand","embeddable":true,"href":"https:\/\/novameds.health\/fr\/wp-json\/wp\/v2\/product_brand?post=794"},{"taxonomy":"product_cat","embeddable":true,"href":"https:\/\/novameds.health\/fr\/wp-json\/wp\/v2\/product_cat?post=794"},{"taxonomy":"product_tag","embeddable":true,"href":"https:\/\/novameds.health\/fr\/wp-json\/wp\/v2\/product_tag?post=794"},{"taxonomy":"nm_classification","embeddable":true,"href":"https:\/\/novameds.health\/fr\/wp-json\/wp\/v2\/nm_classification?post=794"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}